Please use this identifier to cite or link to this item:
|Title:||Antiphospholipid syndrome in renal transplantation.|
|Epworth Authors:||Cohney, Solomon (Shlomo)|
|Other Authors:||Barbour, Thomas|
Kidney Failure, Chronic
Predictive Value of Tests
Systemic Lupus Erythematosus
End-Stage Kidney Disease
UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia
Department of Nephrology, Epworth HealthCare, Richmond, Victoria, Australia.
Department of Gastroenterology, Epworth HealthCare, Richmond, Victoria, Australia.
|Citation:||Nephrology (Carlton). 2014 Apr;19(4):177-85.|
|Abstract:||Antiphospholipid syndrome (APS) may occur in isolation or in association with systemic lupus erythematosus (SLE), with the potential to cause renal failure via several distinct pathologies. Renal transplantation in the presence of APS carries a risk of early graft loss from arterial or venous thrombosis, or thrombotic microangiopathy (TMA). Whilst perioperative anticoagulation reduces the risk of large vessel thrombosis, it may result in significant haemorrhage, and its efficacy in preventing post-transplant TMA is uncertain. Here, we report a patient with end-stage kidney disease (ESKD) due to lupus nephritis and APS, in whom allograft TMA developed soon after transplantation despite partial anticoagulation. TMA resolved with plasma exchange-based therapy albeit with some irreversible graft damage and renal impairment. We discuss the differential diagnosis of post-transplant TMA, and current treatment options.|
|Journal Title:||Nephrology (Carlton)|
|Affiliated Organisations:||Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.|
Department of Anatomical Pathology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Nephrology & Medicine, Northwestern Academic Centre, University of Melbourne, Melbourne, Victoria, Australia.
Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
|Type of Clinical Study or Trial:||Case Reports|
|Appears in Collections:||UroRenal, Vascular|
Files in This Item:
There are no files associated with this item.
Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.